// App-Quantinova.ai

1057 : Patients With End Stage Congestive Heart Failure Have Decreased High Molecular Weight Von Willebrand Factor Multimers and Higher Plasma Levels Of Total TGF-?1: Implantation Of a Left Ventricular Assist Devices (LVAD) Exacerbates Both Abnormalities

Researchers

Presenter

  • Jasimuddin Ahamed

Principal Investigators

  • Juan Monteagudo

  • Mona Kinkhabwala

  • Mayte Suarez-Farinas

  • Arthur Reshad Garan

  • Barry S. Coller

  • Donna Mancini

Medical Centers

  • Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY

  • The Rockefeller University, New York, NY

  • Columbia University, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Congestive heart failure

  • Venous thrombosis

Biomarkers

  • Platelet Factor 4

  • Thrombospondin-1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved